{"id":478208,"date":"2020-04-07T11:48:01","date_gmt":"2020-04-07T11:48:01","guid":{"rendered":"https:\/\/www.abnewswire.com\/pressreleases\/?p=478208"},"modified":"2020-04-07T11:48:01","modified_gmt":"2020-04-07T11:48:01","slug":"hypoparathyroidism-epidemiology-forecast-to-2030","status":"publish","type":"post","link":"https:\/\/www.abnewswire.com\/pressreleases\/hypoparathyroidism-epidemiology-forecast-to-2030_478208.html","title":{"rendered":"Hypoparathyroidism Epidemiology Forecast to 2030"},"content":{"rendered":"
\"Hypoparathyroidism<\/a><\/p>\n
\n
Delveinsight Business Research<\/div>\n<\/div>\n<\/div>\n
DelveInsight’s ‘Hypoparathyroidism Epidemiology Forecast to 2030’ report delivers an in-depth understanding of the disease, historical and forecasted Hypoparathyroidism epidemiology in the 7MM, i.e., the United States, EU5 (Germany, Spain, Italy, France, and the United Kingdom), and Japan.<\/p>\n<\/div>\n

Hypoparathyroidism is a rare endocrine disorder characterized by low-calcium and high-phosphate levels, in the setting of a simultaneously low or inappropriate level of normal Parathyroid hormone (PTH). The most frequent etiology is surgical removal or loss of viability of parathyroid glands. The second most common etiology is autoimmune hypoparathyroidism, related to autoimmune polyglandular syndrome type 1 or isolated hypoparathyroidism due to activating antibodies to the CaSR.<\/p>\n

Severe hypomagnesemia is an uncommon but reversible cause of hypoparathyroidism. Other rarer causes of hypoparathyroidism include infiltrative disorders, such as hemochromatosis, metastases or granulomatous diseases, radiation-induced destruction of parathyroid glands, hungry bone syndrome post parathyroidectomy and HIV infection, and others.<\/p>\n

The DelveInsight Hypoparathyroidism epidemiology report gives a thorough understanding of the Hypoparathyroidism by including details such as disease definition, symptoms, causes, pathophysiology, and diagnosis. <\/p>\n

It also provides <\/span>treatment algorithms and treatment guidelines for Hypoparathyroidism<\/span><\/a> in the US, Europe, and Japan. The report covers the detailed information of the Hypoparathyroidism epidemiology scenario in seven major countries (US, EU5, and Japan).<\/span><\/p>\n

 <\/span><\/span><\/p>\n

Key Highlights Of The Report<\/strong><\/p>\n